Squamous cell carcinoma arises from multiple anatomic subsites in the head and neck
region. The risk factors for development of cancers of the oral cavity, oropharynx …

Radiotherapy (RT) is used to treat approximately 80% of patients with cancer of the head
and neck. Despite enormous advances in RT planning and delivery, a significant number of …

PURPOSE Definitive or postoperative chemoradiation (CRT) is curative for human
papillomavirus–associated (HPV+) oropharynx cancer (OPC) but induces significant toxicity …

Processes of intraoperative diagnosis and elimination of tumors or micro-tumors or cancer
cells or tumor micro environment (TME) with plasmonic nanobubbles (PNBS) are disclosed …

Purpose Human papillomavirus (HPV)–associated oropharyngeal squamous cell carcinoma
(OPSCC) is treatment-responsive. Definitive chemoradiation results in high cure rates but …

Background Head and neck cancers positive for human papillomavirus (HPV) are
exquisitely radiosensitive. We investigated whether chemoradiotherapy with reduced-dose …

Human papillomavirus–positive oropharyngeal squamous cell carcinoma (HPV-OPSCC)
has one of the most rapidly increasing incidences of any cancer in high-income countries …

Most new radiation techniques, have been introduced primarily to reduce the dose to normal
tissues in order to prevent radiation-induced side effects. Radiotherapy with protons is such …

Background Most newly diagnosed oropharyngeal and hypopharyngeal cancers are treated
with chemoradiotherapy with curative intent but at the consequence of adverse effects on …

Purpose There is a large body of evidence supporting the efficacy of low-level laser therapy
(LLLT), more recently termed photobiomodulation (PBM) for the management of oral …